Meningoencephalitis associated with Parvovirus B19 Infection in an Immunocompetent Patient

Article information

Kosin Med J. 2015;30(2):181-185
Publication date (electronic) : 2015 January 20
doi : https://doi.org/10.7180/kmj.2015.30.2.181
Department of Neurology, College of Medicine, Kosin University, Busan, Korea
Corresponding Author: Bong-Goo Yoo, MD, PhD Department of Neurology, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 49267, Korea TEL: +82-51-990-6364 FAX: +82-51-990-3077 E-mail: ybgne@kosinmed.or.kr
Received 2015 November 30; 2015 November 30; Accepted 2015 November 30.

Abstract

Abstract

Parvovirus B19 (PVB19) infection is a rare cause of meningoencephalitis. A 53-year-old previously healthy woman presented with fever, headache, and multiple erythema on the both legs. Cerebrospinal fluid study revealed pleocytosis and elevated opening pressure and protein level. Brain MRI showed multiple, asymmetric, hyperintensity in the brain stem, basal ganglia, white matter, and gray matter. Anti-B19 IgM antibody and PCR for PVB19 were positive in serum. Clinician should consider PVB19 infection in any case of acute febrile illness with erythema and meningoencephalitis

Fig. 1.

Axial FLAIR images show multiple, diffuse, asymmetric hyperintensities involving pons, midbrain, temporal lobe, bilateral thalami, basal ganglia, deep white matter, and temporal and occipital cortex.

Fig. 2.

Follow-up FLAIR images 6 months later demonstrate normal without any residual lesions.

References

1. Koch WC. Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis 2001;14:343–56.
2. Douvoyiannis M, Litman N, Goldman DL. Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis 2009;48:1713–23.
3. Barah F, Vallely PJ, Cleator GM, Kerr JR. Neurological manifestations of human parvovirus B19 infection. Rev Med Virol 2003;13:185–99.
4. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001;358:729–30.
5. Bonvicini F, Marinacci G, Pajno MC, Gallinella G, Musiani M, Zerbini M. Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman. Clin Infect Dis 2008;47:385–7.
6. Tonnellier M, Bessereau J, Carbonnell N, Guidet B, Méritet JF, Kerr JR, et al. A possible parvovirus B19 encephalitis in an immunocompetent adult patient. J Clin Virol 2007;38:186–7.
7. Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006;260:285–304.
8. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350:586–97.
9. Kerr JR, Barah F, Chiswick ML, McDonnell GV, Smith J, Chapman MD, et al. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatry 2002;73:739–46.
10. Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999;21:661–3.

Article information Continued

Fig. 1.

Axial FLAIR images show multiple, diffuse, asymmetric hyperintensities involving pons, midbrain, temporal lobe, bilateral thalami, basal ganglia, deep white matter, and temporal and occipital cortex.

Fig. 2.

Follow-up FLAIR images 6 months later demonstrate normal without any residual lesions.